Weekly Recap: 14 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including updates in glaucoma, reproductive care, sleep health, weight loss and more.

NEW YORK, Aug. 15, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

1. Cardinal Health announces the addition of Solaris Health, the country's leading urology MSO, to The Specialty Alliance
   The transaction accelerates Cardinal Health's multi-specialty growth strategy by extending the reach of The Specialty Alliance, led by CEO James Weber, MD. Taken together with the recent acquisitions of Urology America and Potomac Urology and the just-completed acquisition of Academic Urology & Urogynecology, the acquisition of Solaris Health brings immediate scale to the Urology Alliance within The Specialty Alliance.
2. Community Hospital Corporation Announces $400 Million Heritage Regional Medical Center in Sherman, Texas 
   The newly planned facility, Heritage Regional Medical Center (HRMC), will set a new benchmark for modern health care delivery by combining advanced technology, thoughtful design, and compassionate patient care for the Sherman and surrounding community. Heritage Regional Medical Center is planning to open to the public in early 2028.
3. The Galien Foundation Announces 2025 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup" 
   To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate tremendous potential to improve human health. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.
4. ProBio Launches GMP AAV Manufacturing Services at Hopewell Facility to Advance Gene Therapy Development and Manufacturing 
   ProBio's new capabilities offer clients fully integrated services—including GMP plasmid DNA production, AAV vector manufacturing, and final drug product formulation and aseptic fill/finish—within a single U.S.-based location. This streamlined approach simplifies coordination, reduces handoffs, and accelerates timelines across the drug development lifecycle.
5. Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma
   The Calibreye System is engineered to put aqueous outflow control in the hands of ophthalmologists and give them the opportunity to provide personalized therapy while minimizing complications. Once implanted, the Calibreye aqueous shunt is designed to enable slit lamp-based outflow adjustments as individual patient needs change.
6. Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's disease 
   The NEPTUNUS pivotal trials achieved the primary endpoint of improving disease activity measured by a reduction in EULAR Sjögren's syndrome disease activity index (ESSDAI), a multi-dimensional disease activity measurement compared to placebo. Ianalumab was well tolerated and demonstrated a favorable safety profile in Sjögren's disease.
7. MyOme Joins Mayo Clinic Platform_Accelerate Cohort to Advance Preventative Care 
   As a member of the Mayo Clinic Platform_Accelerate cohort, MyOme will apply its Integrated Risk Models (IRMs) technology that combines whole-genome sequencing, polygenic risk scores (PRS), and AI analysis of clinical data to identify people at heightened risk for common conditions including cardiometabolic diseases and cancers. The work supports an overarching mission to shift healthcare from reactive to proactive care.
8. Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology 
   This newly issued patent builds on Anixa's growing portfolio of CAR-T intellectual property, collectively designed to protect the platform's use across multiple tumor types. This patent, along with others, was granted to The Wistar Institute and exclusively licensed to Anixa Biosciences.
9. Aquedeon Medical Inc. Receives FDA Approval to Expand Clinical Trial of Duett Vascular Graft System 
   AMI is developing the Duett System to address a critical need in open surgical thoracic aortic arch reconstruction, a complex and high-risk procedure typically performed during deep hypothermic circulatory arrest (DHCA) while the patient is on cardiopulmonary bypass. DHCA duration is a critical factor that directly impacts patient outcomes.
10. Gameto's $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial 
    The Series C funding enables Gameto to complete the ongoing Phase 3 trial for its lead program, Fertilo, and file for regulatory approvals globally. Fertilo is currently used in clinics in Peru, Mexico and Australia, with additional clearances in Japan, India, Singapore, Guatemala, Argentina, Dominican Republic, and Paraguay. Five babies have been born with Fertilo so far and over 20 pregnancies have been recorded.
11. NRx Pharmaceuticals, Inc. Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression 
    This designation expands the addressable population for NRX-100 to the 13 million Americans who consider suicide each year and represents a 10x expansion of the addressable population compared to the Designation granted in 2017 for bipolar depression alone.
12. Seragon Launches Sleep and Longevity Optimizer Enlivien® 
    Enlivien is designed to preserve redox homeostasis and support mitochondrial function. These systems are especially vulnerable during periods of sleep disruption, when ROS accumulates and overwhelms the body. Enlivien targets the cascade of biological disruptions linked to impaired nutrient absorption, compromised intestinal barrier integrity, and increased mortality risk observed in preclinical studies.
13. OIKOS® Launches First-of-Its-Kind Cultured Dairy Drink Featuring A Patented Blend of Nutrients Designed to Help Build & Retain Muscle Mass During Weight Loss
    OIKOS FUSION is the first and only product in the yogurt category specifically created and positioned to support the unique nutrition needs of GLP-1 users and other weight loss consumers, with a patented combination of whey protein, leucine and vitamin D. This proprietary trifecta blend takes intentional muscle support to the next level by helping consumers maximally triggering muscle synthesis when paired with a balanced diet and exercise.
14. SC Johnson Secures World Health Organization Policy Recommendation for Innovative Tool Proven to Help Prevent Malaria and Other Insect-borne Diseases 
    Spatial repellents are tools that, when used, release an active ingredient which repels mosquitoes from a room, preventing mosquitoes from biting people and ultimately lessening the transmission of disease. They can be hung in semi-enclosed spaces, including homes and schools, and are about the size of a sheet of paper. They are easy to use, low-cost, long-lasting and effective.

For more news like this, check out all of the latest health-related releases from PR Newswire.

Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

• Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.
• Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story.
• Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles.
• Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more.

About PR Newswire

PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at [email protected].

SOURCE PR Newswire